April 14, 2021
RegMed Investors’ (RMi) closing bell: “the sure way of gambling is getting something for nothing” after a Tuesday bounce
April 13, 2021
RegMed Investors’ (RMi) closing bell: the gain and the pain with a spike, a flame -up and a shake-off after JNJ vaccine halted
April 12, 2021
RegMed Investors’ (RMi) closing bell: it was scary, staring at the cell and gene therapy sector abyss
April 9, 2021
RegMed Investors’ (RMi) closing bell: just another sector beat-down
April 8, 2021
RegMed Investors’ (RMi) closing bell: backup today, reversing yesterday’s algorithmic curse
April 7, 2021
RegMed Investors’ (RMi) closing bell: barely any distance in the upside
April 6, 2021
RegMed Investors’ (RMi) closing bell: what’s being shaken in today’s sector?
April 5, 2021
RegMed Investors’ (RMi) closing bell: sector didn’t trend far from Thursday’s highs
April 5, 2021
RegMed Investors’ (RMi) closing bell: sector didn’t trend far from Thursday’s highs
April 5, 2021
RegMed Investors’ (RMi) closing bell: sector didn’t trend far from Thursday’s highs
April 1, 2021
RegMed Investors’ (RMi) closing bell: Q2’s much anticipated word, expectation
March 31, 2021
RegMed Investors’ (RMi) closing bell: the month is over as the sector closes out March and the Q1 on a high note
March 30, 2021
RegMed Investors’ (RMi) closing bell: market dumps, sector jumps
March 29, 2021
RegMed Investors’ (RMi) closing bell: flipping the bird to risk
March 26, 2021
RegMed Investors’ (RMi) closing bell: cell and gene therapy sector strength migrated to weakness
March 25, 2021
RegMed Investors’ (RMi) closing bell: the zig and the zag, from weakness to strength in four (4) hours
March 24, 2021
RegMed Investors’ (RMi) closing bell: we are suffering from a lack of appetite for cell and gene therapy companies
March 23, 2021
RegMed Investors’ (RMi) closing bell: when you acclaim the gains, be ready for the pain
March 22, 2021
RegMed Investors’ (RMi) closing bell: through the prism of an upside markets, some cell and gene therapy equities take a mulligan
March 19, 2021
RegMed Investors’ (RMi) closing bell: sector bounces to some higher pricing
March 18, 2021
RegMed Investors’ (RMi) closing bell: falling knives draw equity blood
March 17, 2021
RegMed Investors’ (RMi) closing bell: sector pops as markets slogs higher
March 16, 2021
RegMed Investors’ (RMi) closing bell: sector retreats on low volume compressing yesterday’s gusto
March 15, 2021
RegMed Investors’ (RMi) closing bell: the sector wobbles as the market reaches new highs
March 12, 2021
RegMed Investors’ (RMi) closing bell: sector resistance rose as support degenerated
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.